MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
LIMN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Liminatus Pharma (LIMN) Ownership - Who owns Liminatus Pharma?

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.93M
P/E Ratio
N/A
Total Cash
1.91M
Projected Growth
N/A
Total Debt
1.44M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.42
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
LIMN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for LIMN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Who owns Liminatus Pharma? LIMN symbol Ownership - Tickeron.com